Valuation: Labcorp Holdings Inc.

Market Cap 24.34B 21.41B 19.9B 18.27B 34.29B 2,350B 34.87B 236B 92.29B 1,152B 91.35B 89.38B 3,986B P/E 2026 *
20.5x
P/E 2027 * 19.3x
Enterprise Value 28.97B 25.49B 23.69B 21.75B 40.82B 2,797B 41.51B 281B 110B 1,371B 109B 106B 4,745B EV / Sales 2026 *
1.97x
EV / Sales 2027 * 1.83x
Free-Float
99.65%
Yield 2026 *
0.98%
Yield 2027 * 0.99%
1 day+1.98%
1 week+5.26%
Current month+5.99%
1 month+14.76%
3 months+12.02%
6 months+11.29%
Current year+18.29%
1 week 277.04
Extreme 277.035
298.58
1 month 262.1
Extreme 262.105
298.58
Current year 245
Extreme 245
298.58
1 year 244.52
Extreme 244.52
298.58
3 years 191.97
Extreme 191.97
298.58
5 years 191.97
Extreme 191.97
317.17
10 years 98.02
Extreme 98.02
317.17
Date Insider Type Main position Quantity % Market Cap.
7/2/26 A Sell

EVP and President, Diagnostics

-234 0.0003%
7/2/26 A Sell

General Counsel

-92 0.0001%
6/8/26 A Sell

General Counsel

-762 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
+1.98%+5.26%+18.47%+35.38% 23.86B
-1.02%-2.91%+90.10%+431.31% 37.91B
+2.02%-2.39%-24.11%-39.95% 7.16B
+0.97%-2.25%+5.18%+75.96% 4.8B
+4.27%+1.53%+16.61%+53.85% 2.91B
-6.75%-4.20%-28.75%+649.05% 1.88B
-2.07%-6.92%-12.71%-63.55% 1.81B
-2.46%-6.40%+110.14%-20.36% 1.85B
+5.58%-1.99%+14.91%+3.77% 1.77B
-5.15%-26.06%-0.13%-34.06% 1.49B
Average -0.26%-2.79%+18.97%+109.14% 8.55B
Weighted average by Cap. +0.25%-0.92%+45.75%+215.95%

Financials

2026 *2027 *
Net sales 14.71B 12.94B 12.03B 11.05B 20.73B 1,420B 21.08B 143B 55.79B 696B 55.22B 54.03B 2,410B 15.42B 13.57B 12.61B 11.58B 21.73B 1,489B 22.09B 150B 58.47B 730B 57.87B 56.63B 2,525B
Net income 1.18B 1.04B 969M 889M 1.67B 114B 1.7B 11.51B 4.49B 56.07B 4.45B 4.35B 194B 1.23B 1.08B 1.01B 924M 1.73B 119B 1.76B 11.95B 4.66B 58.22B 4.62B 4.52B 201B
Net Debt 4.63B 4.08B 3.79B 3.48B 6.53B 447B 6.64B 45B 17.57B 219B 17.39B 17.02B 759B 3.95B 3.47B 3.23B 2.96B 5.56B 381B 5.65B 38.31B 14.96B 187B 14.81B 14.49B 646B
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
24/07/26 $296.77 +1.98% 907,427
23/07/26 $291.02 +3.40% 1,506,096
22/07/26 $281.46 +0.74% 854,980
21/07/26 $279.40 -0.74% 793,930
20/07/26 $281.48 -0.66% 777,645
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
296.77USD
Average target price
312.35USD
Spread / Average Target
+5.25%

Quarterly revenue - Rate of surprise